THE PEW CHARITABLE TRUSTS named 22 early-career researchers as Pew scholars in the biomedical sciences—as well as five scholars for cancer research, funded in partnership with the Alexander and Margaret Stewart Trust.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
